Lotus Pharmaceutical Co., Ltd. (TPE: 1795)
Taiwan
· Delayed Price · Currency is TWD 269.00
+4.50 (1.70%)
Jan 6, 2025, 1:30 PM CST
Lotus Pharmaceutical Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 3, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 72,187 | 71,935 | 64,462 | 25,569 | 19,628 | 27,958 | Upgrade
|
| Market Cap Growth | 11.62% | 11.59% | 152.11% | 30.27% | -29.79% | 58.40% | Upgrade
|
| Enterprise Value | 80,939 | 81,666 | 71,660 | 30,851 | 25,397 | 34,043 | Upgrade
|
| Last Close Price | 272.00 | 267.14 | 238.79 | 93.27 | 76.28 | 109.65 | Upgrade
|
| PE Ratio | 16.50 | 17.52 | 21.34 | 18.22 | 19.12 | 42.18 | Upgrade
|
| Forward PE | 12.16 | 15.36 | 18.39 | 15.41 | 16.33 | 22.83 | Upgrade
|
| PS Ratio | 4.04 | 4.24 | 4.41 | 2.02 | 1.83 | 2.91 | Upgrade
|
| PB Ratio | 3.57 | 4.15 | 4.65 | 2.31 | 2.24 | 3.62 | Upgrade
|
| P/TBV Ratio | 8.18 | 11.65 | 28.14 | 10.18 | - | - | Upgrade
|
| P/FCF Ratio | 16.72 | 59.76 | 20.51 | - | 12.79 | 323.08 | Upgrade
|
| P/OCF Ratio | 15.09 | 44.56 | 17.33 | 213.68 | 10.07 | 66.57 | Upgrade
|
| EV/Sales Ratio | 4.60 | 4.82 | 4.90 | 2.44 | 2.37 | 3.54 | Upgrade
|
| EV/EBITDA Ratio | 12.28 | 13.23 | 14.07 | 9.63 | 10.74 | 18.62 | Upgrade
|
| EV/EBIT Ratio | 15.20 | 16.07 | 16.86 | 12.20 | 14.59 | 24.12 | Upgrade
|
| EV/FCF Ratio | 18.75 | 67.85 | 22.81 | - | 16.55 | 393.40 | Upgrade
|
| Debt / Equity Ratio | 0.62 | 0.67 | 0.64 | 0.63 | 0.78 | 0.95 | Upgrade
|
| Debt / EBITDA Ratio | 1.89 | 1.84 | 1.72 | 2.12 | 2.80 | 3.85 | Upgrade
|
| Debt / FCF Ratio | 2.88 | 9.62 | 2.84 | - | 4.45 | 84.92 | Upgrade
|
| Asset Turnover | 0.50 | 0.54 | 0.58 | 0.62 | 0.57 | 0.58 | Upgrade
|
| Inventory Turnover | 1.94 | 2.13 | 2.13 | 2.65 | 3.45 | 4.15 | Upgrade
|
| Quick Ratio | 1.80 | 1.85 | 1.17 | 1.16 | 0.88 | 1.19 | Upgrade
|
| Current Ratio | 2.54 | 2.80 | 1.81 | 1.93 | 1.39 | 1.85 | Upgrade
|
| Return on Equity (ROE) | 23.42% | 26.32% | 24.23% | 14.17% | 12.48% | 8.81% | Upgrade
|
| Return on Assets (ROA) | 9.48% | 10.16% | 10.47% | 7.71% | 5.73% | 5.34% | Upgrade
|
| Return on Capital (ROIC) | 10.87% | 12.29% | 13.02% | 9.41% | 7.10% | 6.41% | Upgrade
|
| Earnings Yield | 6.06% | 5.71% | 4.69% | 5.49% | 5.23% | 2.37% | Upgrade
|
| FCF Yield | 5.98% | 1.67% | 4.87% | -1.77% | 7.82% | 0.31% | Upgrade
|
| Dividend Yield | 1.73% | 1.74% | 1.45% | 2.07% | 0.46% | - | Upgrade
|
| Payout Ratio | 28.43% | 22.07% | 16.75% | 6.56% | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.37% | -0.13% | -1.95% | -5.43% | -0.65% | -1.55% | Upgrade
|
| Total Shareholder Return | 1.36% | 1.61% | -0.50% | -3.36% | -0.19% | -1.55% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.